Market Dynamics The global impetigo market is anticipated to demonstrate a strong revenue compound annual growth rate (CAGR) during the forecast period spanning from 2019 to 2030. Market revenue growth is primarily fueled by the increase in infectious diseases, a rising percentage of individuals with compromised immunity, the escalating use of antibiotics, and a growing infant population. Impetigo, also known as school sores, is a type of skin infection that predominantly affects infants and young children. It is highly contagious and typically manifests as red sores around the nose and mouth. Impetigo is caused by one or both of the bacteria, Streptococcus and Staphylococcus aureus.
According to the World Health Organization (WHO), approximately 162 million individuals worldwide suffer from impetigo.
Factors Supporting Market Growth Drivers The impetigo treatment market is driven by several factors, including the surge in infectious disease outbreaks and a patient population with weakened immune systems. According to the U.S. Centers for Disease Control and Prevention, 3% of the U.S. population suffers from weakened immune systems.
Get a sample copy of the Impetigo Market report: https://www.reportsanddata.com/download-free-sample/5355
Global increases in antibiotic usage, the rise in hospital-acquired infections, an expanding infant population, and the adoption of unhygienic lifestyles in developing nations are key drivers of market growth. Additionally, the growing demand for broad-spectrum antibiotics, ongoing research and development efforts to enhance the quality of impetigo treatment drugs, and increased healthcare spending contribute to market growth. Notably, global antibiotic consumption increased by 65% between 2000 and 2015.
Restraints The main restraining factors for market growth include side effects such as irritation and canker sores associated with impetigo drugs and the presence of generic medications.
Opportunities Government initiatives to expedite regulatory approvals for novel drugs and advancements in emerging markets are expected to offer potential for market expansion.
Largest Market Share The North American market is projected to experience robust revenue growth during the forecast period due to the rising prevalence of infectious diseases, an increasing infant population, and significant investments by key players in research and development.
According to the American Academy of Family Physicians, the frequency of impetigo in the UK is 2.8% in children under the age of four and 1.6% in children aged five to fifteen. Key factors driving market growth in North America include a well-established healthcare infrastructure, the adoption of innovative products, and an increase in hospital-acquired infections.
Fastest Growing Region The Asia Pacific region is expected to grow at the highest rate during the forecast period due to the increasing incidence of infectious diseases, a growing infant population, improvements in healthcare facilities, and increased research and development efforts aimed at improving the quality of impetigo treatment drugs.
What Our Report Provides and Why Our Offering Is Superior This report offers historical data points, forecasts, and revenue growth at global, regional, and country levels. It provides analysis of industry trends and consumption patterns for each region, major country, and segment from 2019 to 2030. The global market report includes insights into industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and revenue share contributions for each regional and country market. Additionally, the report offers industry analysis and a competitive landscape, including company financials and impact analysis.
Key Market Trends and Innovation: The impetigo market is witnessing a trend toward new treatment options and combination drugs.
Clinical trials have been conducted to evaluate the safety and efficacy of topical application of mupirocin on children with impetigo in various locations.
Organic and Inorganic Strategies Adopted: In June 2019, Almirall collaborated with the American Acne and Rosacea Society (AARS) to raise awareness of the prevalence and effects of impetigo in the U.S. This collaboration is expected to enhance knowledge of skin disease treatments and their effectiveness.
In September 2019, Almirall LLC acquired the Allergan US Medical Dermatology Unit, a move aimed at expanding its business portfolio and strengthening its brand recognition in the impetigo treatment market.
In November 2018, Cutanea Life Sciences launched Xepi cream 1%, a non-fluorinated topical quinolone cream for the treatment of impetigo in adults.
In December 2017, Medimetriks Pharmaceutical introduced a topical ozenoxacin cream approved by the FDA for the treatment of impetigo.
Major Companies in the Market Include: Key Players:
- Teva Pharmaceuticals Industries Ltd.
- Pfizer Inc.
- GlaxoSmithKline plc.
- Ranbaxy Laboratories Limited
- Lupin Limited
- Roche Holding AG
- Sandoz GmbH
- Karalex Pharma, LLC.
- Leo Pharma A/S
- Novabay Pharmaceuticals
- Ojer Pharma
Treatment Outlook:
- Penicillin
- Quinolones
- Cephalosporins
- Fusidane
- Sulfonamides
- Tetracycline
- Lincosamide
Route of Administration Outlook:
- Oral
- Topical
Product Outlook:
- Gels
- Cream
- Ointment
- Tablet
- Capsule
Distribution Channel Outlook:
- Online
- Offline
End-Users Outlook:
- Hospitals
- Healthcare Clinics
- Specialty Clinics
- Others
Region Outlook:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Explore Trending Reports:
Temperature Controlled Packaging Solutions Market-https://www.globenewswire.com/news-release/2019/05/07/1818660/0/en/Global-Temperature-Controlled-Packaging-Solutions-Market-To-Reach-USD-18-01-Billion-By-2026-Reports-And-Data.html
Anti-Counterfeit Packaging Market-https://www.globenewswire.com/news-release/2019/09/05/1911804/0/en/Anti-Counterfeit-Packaging-Market-To-Reach-USD-248-90-Billion-By-2026-Reports-And-Data.html
Blow-Fill-Seal Technology Market-https://www.globenewswire.com/news-release/2019/10/01/1923555/0/en/Blow-Fill-Seal-Technology-Market-To-Reach-USD-452-6-Million-By-2026-Reports-And-Data.html
Oxygen Scavengers Market-https://www.globenewswire.com/news-release/2020/09/15/2094192/0/en/Oxygen-Scavengers-Market-To-Reach-USD-2-78-Billion-By-2027-Reports-and-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5355
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
